These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24470446)

  • 1. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
    Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
    Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.
    Haga H; Egawa H; Fujimoto Y; Ueda M; Miyagawa-Hayashino A; Sakurai T; Okuno T; Koyanagi I; Takada Y; Manabe T
    Liver Transpl; 2006 Mar; 12(3):457-64. PubMed ID: 16498648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts.
    Bröcker V; Pfaffenbach A; Habicht A; Chatzikyrkou C; Kreipe HH; Haller H; Scheffner I; Gwinner W; Zilian E; Immenschuh S; Schwarz A; Horn PA; Heinemann FM; Becker JU
    Nephrol Dial Transplant; 2013 Dec; 28(12):3101-9. PubMed ID: 24081856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.
    Miyagawa-Hayashino A; Yoshizawa A; Uchida Y; Egawa H; Yurugi K; Masuda S; Minamiguchi S; Maekawa T; Uemoto S; Haga H
    Liver Transpl; 2012 Nov; 18(11):1333-42. PubMed ID: 22888064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients.
    Dao M; Habès D; Taupin JL; Mussini C; Redon MJ; Suberbielle C; Jacquemin E; Gonzales E; Guettier C
    Liver Transpl; 2018 Jul; 24(7):897-907. PubMed ID: 29704327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.
    Kozlowski T; Andreoni K; Schmitz J; Hayashi PH; Nickeleit V
    Liver Transpl; 2012 Jun; 18(6):641-58. PubMed ID: 22298469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
    Collins AB; Chicano SL; Cornell LD; Tolkoff-Rubin N; Goes NB; Saidman SL; Farrell ML; Cosimi AB; Colvin RB
    Transplant Proc; 2006 Dec; 38(10):3427-9. PubMed ID: 17175293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
    Musat AI; Pigott CM; Ellis TM; Agni RM; Leverson GE; Powell AJ; Richards KR; D'Alessandro AM; Lucey MR
    Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated rejection in the liver allograft.
    Hübscher SG
    Curr Opin Organ Transplant; 2012 Jun; 17(3):280-6. PubMed ID: 22569512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status.
    Bellamy CO; Herriot MM; Harrison DJ; Bathgate AJ
    Histopathology; 2007 May; 50(6):739-49. PubMed ID: 17493238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
    Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritubular capillary deposition of C4d complement fragment in ABO-incompatible renal transplantation with humoral rejection.
    Onitsuka S; Yamaguchi Y; Tanabe K; Takahashi K; Toma H
    Clin Transplant; 1999; 13 Suppl 1():33-7. PubMed ID: 10751054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
    O'Leary JG; Kaneku H; Demetris AJ; Marr JD; Shiller SM; Susskind BM; Tillery GW; Terasaki PI; Klintmalm GB
    Liver Transpl; 2014 Feb; 20(2):218-27. PubMed ID: 24382837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.
    Haas M; Segev DL; Racusen LC; Bagnasco SM; Locke JE; Warren DS; Simpkins CE; Lepley D; King KE; Kraus ES; Montgomery RA
    J Am Soc Nephrol; 2009 Jan; 20(1):197-204. PubMed ID: 18776120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
    Roberts JA; Barrios R; Cagle PT; Ge Y; Takei H; Haque AK; Burns KM; Land GA; Dilioglou S; Bernard DW
    Arch Pathol Lab Med; 2014 Aug; 138(8):1053-8. PubMed ID: 24164556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection.
    Martelius T; Halme L; Arola J; Höckerstedt K; Lautenschlager I
    Transpl Immunol; 2009 Sep; 21(4):244-6. PubMed ID: 19540918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis.
    Aguilera I; Sousa JM; Gavilan F; Gomez L; Alvarez-Márquez A; Núñez-Roldán A
    Liver Transpl; 2011 Jul; 17(7):779-88. PubMed ID: 21425430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.